A growing number of lawsuits alleged that the manufacturers of certain GLP-1 drugs like Ozempic, Wegovy, and Mounjaro failed ...

Medicare wants to negotiate lower prices for Eli Lilly's GLP-1 drug Trulicity and AbbVie's Botox in its next round of ...

As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...

Good morning. A new startup focused on GLP-1 drugs launched today, but unlike the dozens of other GLP-1 companies, this one isn’t studying weight loss. Roche plans to launch Phase 3 studies of its ...

According to doctors, making a misstep is easier than you may think.

FDA-approved oral GLP-1s match injectables in weight loss effectiveness with similar side effects and health benefits. There are differences, however.

Tirzepatide users on hormone therapy had added improvements in weight, cardiometabolic mar ...

Weight-loss drugs keep gaining traction - is that a blessing or a curse for the packaging industry? We dive deeper into the ...

Nugevia™ supports metabolic, mitochondrial, and neuroinflammatory biology impacted by GLP-1-driven weight loss ...

Insurers cite unsustainable costs as GLP-1 benefits disappear, accelerating a national shift in employer-sponsored ...

Are GLP-1 drugs prescribed for weight loss becoming too outsized a line item for continued coverage through the state ...

Scammers are using AI and celebrity deepfakes to sell fake GLP-1 weight-loss pills, creating ads that look and sound ...